VERTEX PHARMACEUTICALS INC / MA Goodwill, Period Increase (Decrease)
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Goodwill, Period Increase (Decrease) of $0 for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-04.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillPeriodIncreaseDecrease · last filed 2015-05-04
- VERTEX PHARMACEUTICALS INC / MA goodwill, period increase (decrease) for the quarter ending 2015-03-31 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA goodwill, period increase (decrease) for the quarter ending 2014-09-30 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA goodwill, period increase (decrease) for the quarter ending 2014-06-30 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA goodwill, period increase (decrease) for the quarter ending 2014-03-31 was $0.00.
| Period end | Goodwill, Period Increase (Decrease) 3 month | Goodwill, Period Increase (Decrease) 6 month | Goodwill, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2015-03-31 | $0.00 10-Q · filed 2015-05-04 | ||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | $0.00 10-Q · filed 2014-11-06 |
| 2014-06-30 | $0.00 10-Q · filed 2014-07-31 | $0.00 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-04 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | $0.00 10-Q · filed 2014-11-06 |
| 2013-06-30 | $0.00 10-Q · filed 2014-07-31 | $0.00 10-Q · filed 2014-07-31 | |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-05 | ||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 |
| 2012-06-30 | $0.00 10-Q · filed 2013-08-02 | $0.00 derived: sum of 2 quarters · filed 2013-08-02 | |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |